Abbott Diabetes Care, Inc.: Medical Device Recall in 2024 - (Recall #: Z-0734-2024)

Updated on March 25, 2026.

See the recall detail below. You can also see other recalls from the same firm in 2024.

Data Source: FDA.

Product Description:

FreeStyle Libre 3 App, part of Continuous Glucose Monitoring System, when used on the Android 13 Operating System

Product Classification:

Class II

Date Initiated: February 9, 2023

Date Posted: January 24, 2024

Recall Number: Z-0734-2024

Event ID: 93393

Reason for Recall:

If using affected glucose monitoring app on Android 13 Operating System, extended periods of signal loss may be experienced, due to app not connected, which could impact ability to receive glucose reading/alarms, which could lead to undetected low or high glucose, which could result in delayed treatment: not taking insulin (for high glucose), or not taking glucose (for low glucose) when required.

Status: Completed

Product Quantity: 45,173

Code Information:

UDI-DI: 00357599816001, Software v.3.4.0 and below

Distribution Pattern:

US Nationwide distribution in the states of NY, CA, NJ, UT, PA, MS, OH, TX, MN, FL, LA, NE, MI, VA, NC, MA, IN, SC, IA.

Voluntary or Mandated:

Voluntary: Firm initiated